CanniMed Therapeutics (TSE:CMED) Trading Down 5.3% – Here’s Why
CanniMed Therapeutics Inc. (TSE:CMED – Get Free Report)’s stock price fell 5.3% on Monday . The stock traded as low as C$27.00 and last traded at C$27.00. 52,208 shares were traded during trading, a decline of 87% from the average session volume of 387,394 shares. The stock had previously closed at C$28.50. CanniMed Therapeutics Price […]
More Stories
Surgery Partners (NASDAQ:SGRY) Research Coverage Started at Bank of America
Bank of America started coverage on shares of Surgery Partners (NASDAQ:SGRY – Free Report) in a research report released on...
Keros Therapeutics (NASDAQ:KROS) Price Target Cut to $63.00 by Analysts at Oppenheimer
Keros Therapeutics (NASDAQ:KROS – Free Report) had its price target trimmed by Oppenheimer from $102.00 to $63.00 in a report...
Digihost Technology’s (DGHI) Buy Rating Reiterated at HC Wainwright
HC Wainwright reiterated their buy rating on shares of Digihost Technology (NASDAQ:DGHI – Free Report) in a research report sent...
a.k.a. Brands (NYSE:AKA) Earns Buy Rating from Analysts at Lake Street Capital
Lake Street Capital assumed coverage on shares of a.k.a. Brands (NYSE:AKA – Free Report) in a research note issued to...
Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Receives Consensus Recommendation of “Hold” from Brokerages
Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS – Get Free Report) has received a consensus rating of “Hold” from the eleven analysts that...
Occidental Petroleum Co. (NYSE:OXY) Receives Consensus Recommendation of “Hold” from Brokerages
Shares of Occidental Petroleum Co. (NYSE:OXY – Get Free Report) have been assigned an average rating of “Hold” from the...